Beneficient Regains Compliance with Nasdaq Periodic Filing Requirement and Market Value of Listed Securities Requirement
Beneficient (NASDAQ: BENF) announced that Nasdaq notified the company on October 29, 2025 that it has regained compliance with two listing standards: (i) the Nasdaq periodic reporting requirement after filing its Form 10-K for fiscal year ended March 31, 2025 and Form 10-Q for quarter ended June 30, 2025, and (ii) the $35 million market value of listed securities requirement as an alternative to the minimum stockholders’ equity test.
The company remains noncompliant with the $1.00 per share bid price requirement and must regain compliance within the extension period granted by the Nasdaq Hearings Panel. If compliance is not achieved, the company plans to seek stockholder approval for a reverse stock split intended to restore the $1.00 bid price for the required 10-consecutive trading day period.
Beneficient (NASDAQ: BENF) ha annunciato che Nasdaq ha informato la società il 29 ottobre 2025 di aver ripreso la conformità con due standard di quotazione: (i) l’obbligo di reporting periodico di Nasdaq dopo aver presentato il Form 10-K per l’anno fiscale terminato il 31 marzo 2025 e il Form 10-Q per il trimestre terminato il 30 giugno 2025, e (ii) l’obbligo di valore di mercato di 35 milioni di dollari delle azioni quotate come alternativa al test minimo di patrimonio netto degli azionisti. L’azienda rimane non conforme al requisito del prezzo di offerta di $1,00 per azione e deve recuperare la conformità entro il periodo di estensione concesso dal Nasdaq Hearings Panel. Se la conformità non sarà raggiunta, l’azienda intende cercare l’approvazione degli azionisti per uno reverse stock split volto a ripristinare il prezzo di offerta a $1,00 durante il periodo minimo di 10 sedute di negoziazione consecutive.
Beneficient (NASDAQ: BENF) anunció que Nasdaq notificó a la empresa el 29 de octubre de 2025 que ha vuelto a cumplir con dos estándares de cotización: (i) el requisito de reporte periódico de Nasdaq tras presentar su Form 10-K para el año fiscal terminado el 31 de marzo de 2025 y el Form 10-Q para el trimestre terminado el 30 de junio de 2025, y (ii) el requisito de valor de mercado de los valores listados de 35 millones de dólares como alternativa a la prueba de patrimonio mínimo de los accionistas. La empresa continúa sin cumplir con el requisito de precio de oferta de $1.00 por acción y debe volver a cumplir dentro del periodo de extensión otorgado por el Panel de Audiencias de Nasdaq. Si no se logra la conformidad, la empresa planea buscar la aprobación de los accionistas para un split inverso destinado a restablecer el precio de oferta de $1.00 durante el periodo de 10 días de negociación consecutivos.
Beneficient(NASDAQ: BENF) 은 Nasdaq가 2025년 10월 29일 회사에 두 가지 상장 표준 준수 여부를 통지했다고 발표했다. (i) 2025년 3월 31일 종료 회계연도에 대한 Form 10-K 및 2025년 6월 30일 분기보고서 Form 10-Q를 제출한 뒤 Nasdaq의 주기적 보고 요건을 준수하는 것, (ii) 상장 주식의 시가 총액 3,500만 달러 요건을 주주 지분 최소 테스트의 대안으로 충족하는 것. 회사는 여전히 주당 1.00달러 매수 요건을 충족하지 못하고 있으며 Nasdaq 청문패널이 부여한 연장 기간 내에 준수해야 한다. 준수를 달성하지 못하면 회사는 요구된 10거래일 연속 기간 동안 주가를 1.00달러로 회복하기 위한 역분할을 주주 승인받을 계획이다.
Beneficent (NASDAQ: BENF) a annoncé que Nasdaq a informé la société le 29 octobre 2025 qu’elle étaitRevenue à la conformité avec deux critères de cotation : (i) l’exigence de rapports périodiques de Nasdaq après le dépôt du Form 10-K pour l’exercice clos au 31 mars 2025 et du Form 10-Q pour le trimestre clos au 30 juin 2025, et (ii) l’exigence de valeur marchande des titres cotés de 35 millions de dollars comme alternative au test de fonds propres minimum des actionnaires. L’entreprise reste non conforme à l’exigence de prix d’offre de 1,00 $ par action et doit regagner la conformité pendant la période d’extension accordée par le Nasdaq Hearings Panel. Si la conformité n’est pas atteinte, l’entreprise prévoit de solliciter l’approbation des actionnaires pour une rallonge inverse destinée à rétablir le prix d’offre à 1,00 $ pendant la période de négociation de 10 jours consécutifs.
Beneficient (NASDAQ: BENF) gab bekannt, dass Nasdaq das Unternehmen am 29. Oktober 2025 darüber informiert hat, dass es die Einhaltung zweier Listing-Standards wiedererlangt hat: (i) die Nasdaq-Periodenberichtsanforderung nach Einreichung des Form 10-K für das Geschäftsjahr zum 31. März 2025 und des Form 10-Q für das Quartal zum 30. Juni 2025, und (ii) die Anforderung einer Marktkapitalisierung der gelisteten Wertpapiere in Höhe von 35 Mio. US-Dollar als Alternative zum Test des Mindestaktionärskapitals. Das Unternehmen bleibt hinsichtlich der Bid-Price von 1,00 USD pro Aktie nicht konform und muss innerhalb der von der Nasdaq-Hearings-Panel gewährten Verlängerungsfrist die Konformität wiederherstellen. Falls die Konformität nicht erreicht wird, plant das Unternehmen, die Zustimmung der Aktionäre für einen Reverse Stock Split zu beantragen, um den Angebotspreis für die erforderlichen 10 aufeinanderfolgenden Handelstage wieder auf 1,00 USD zu bringen.
Beneficient (NASDAQ: BENF) أعلنت أن Nasdaq أبلغت الشركة في 29 أكتوبر 2025 بأنها استعيدت الامتثال لاثنين من معايير الإدراج: (1) متطلبات التقارير الدورية لدى Nasdaq بعد تقديم نموذج 10-K للسنة المالية المنتهية في 31 مارس 2025 ونموذج 10-Q للربع المنتهي في 30 يونيو 2025، و(2) متطلب القيمة السوقية للأسهم المدرجة بمقدار 35 مليون دولار كبديل لاختبار حقوق المساهمين الدنيا. لا تزال الشركة غير متوافقة مع شرط سعر العرض 1.00 دولار للسهم ويجب استعادة الامتثال خلال فترة التمديد التي منحتها لجنة Nasdaq Hearings Panel. إذا لم يتم الامتثال، تخطط الشركة للحصول على موافقة المساهمين لعملية تقسيم عكسي تهدف إلى إعادة سعر العرض إلى 1.00 دولار خلال فترة التداول المتواصلة لمدة 10 أيام.
- Form 10-K filed for fiscal year ended March 31, 2025
- Form 10-Q filed for quarter ended June 30, 2025
- Market value compliance reached: met $35M listed securities requirement
- Bid price noncompliance: remains below $1.00 per share
- Potential reverse split to regain $1.00 bid price requires shareholder approval
DALLAS, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that, by letter dated October 29, 2025, the Company was notified by The Nasdaq Stock Market, LLC (“Nasdaq”) that the Company had regained compliance with (i) the Nasdaq periodic reporting requirement by filing its Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, with the Securities and Exchange Commission, and (ii) the Nasdaq minimum
The Company remains noncompliant with respect to the
About Beneficient
Beneficient (Nasdaq: BENF) – Ben, for short – is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors − mid-to-high net worth individuals, small-to-midsized institutions and General Partners seeking exit options, anchor commitments and valued-added services for their funds – with solutions that could help them unlock the value in their alternative assets. Ben’s AltQuote® tool provides customers with a range of potential exit options within minutes, while customers can log on to the AltAccess® portal to explore opportunities and receive proposals in a secure online environment.
Its subsidiary, Beneficient Fiduciary Financial, L.L.C., received its charter under the State of Kansas’ Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight by the Office of the State Bank Commissioner.
For more information, visit www.trustben.com or follow us on LinkedIn.
Contacts
Matt Kreps: 214-597-8200, mkreps@darrowir.com
Michael Wetherington: 214-284-1199, mwetherington@darrowir.com
Investor Relations: investors@beneficient.com
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the listing and trading of the Company’s securities on Nasdaq and the Company’s intention to regain compliance with the Nasdaq Listing Rules. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on our management’s beliefs, as well as assumptions made by, and information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected.
Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, among others, our ability to timely demonstrate compliance with the bid price requirement within the extension period granted by the Panel, our ability to cure any deficiencies in compliance with any other Nasdaq Listing Rules, our ability to obtain stockholder approval for a reverse stock split of the Company’s common stock, risks related to the substantial costs and diversion of management’s attention and resources due to these matters and the risks, uncertainties, and factors set forth under “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and its subsequently filed Quarterly Reports on Form 10-Q, and the risks and uncertainties contained in the Company’s Current Reports on Form 8-K. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.
Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
FAQ
What filings did Beneficient (BENF) submit to regain Nasdaq periodic reporting compliance?
When did Nasdaq notify Beneficient (BENF) that it regained compliance with listing standards?
Is Beneficient (BENF) still at risk of Nasdaq delisting?
What action might Beneficient (BENF) take if it does not regain the $1.00 bid price?
Does Beneficient (BENF) currently meet Nasdaq's stockholders’ equity requirement?
